Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people begin to notice weight loss on Wegovy within the first four to eight weeks, though the earliest changes are often subtle. Clinical trial data show meaningful body-weight reductions building steadily across the full treatment period, with the greatest losses seen after several months at maintenance dose. Wegovy is a prescription-only medicine; a prescriber assesses whether it is clinically appropriate for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The clearest picture of Wegovy's timeline comes from the STEP 1 trial published in the New England Journal of Medicine, which followed 1,961 adults with obesity over 68 weeks. Weight loss was not a sudden event. It accumulated gradually, with participants losing progressively more as doses increased and time passed. By around week 16, when many participants were reaching or approaching the 1.7 mg dose step, average losses were becoming clinically meaningful. The full 2.4 mg maintenance dose was not reached until around week 17 for most participants, and losses continued to build for months after that.
What this means in practice: if you start Wegovy and the scales have barely shifted after three weeks, that is normal and expected. The titration schedule (0.25 mg rising through 0.5 mg, 1.0 mg and 1.7 mg before reaching 2.4 mg) is paced deliberately. Your prescriber controls that ladder; the pace is not something to rush or adjust yourself.
Many people tell us the first thing they actually notice is not weight on the scales at all. It is eating a portion that would once have felt small and feeling genuinely satisfied. That shift in appetite is the medicine working, and if you are wondering when you actually notice weight loss on Wegovy, appetite change is often the first sign, even before significant scale movement. Worth knowing before you check the scales obsessively in week two.
The 0.25 mg starting dose carries a specific job: helping your body adjust to the GLP-1 mechanism without being overwhelmed by nausea or digestive discomfort. It is not a therapeutic weight-loss dose. During those first four weeks, some people lose a small amount, others none. Both are consistent with how the medicine works.
As doses step up, gastric emptying slows more noticeably, appetite signals change more reliably, and the body's calorie balance shifts. For many people, weeks five to twelve represent the phase where clothes begin to feel differently. The number on the scales often starts to move more consistently somewhere in that window, though this varies quite a bit between individuals.
The NHS medicines information for semaglutide is clear that results depend on following the prescribed dose schedule alongside a reduced-calorie diet and regular physical activity. The injection alone does not replace those foundations; it makes them easier to sustain by reducing hunger.
If you are weighing yourself daily, the natural fluctuation in water weight can mask real progress. A weekly weigh-in, same time of day, is what our prescribers generally suggest as a more meaningful measure, though timing and method are always something to discuss with your own clinical team.
The pattern seen across clinical evidence and real-world use is roughly this: modest early losses in the first month, accelerating losses through months two to four as the dose increases, and the most pronounced changes building through months four to twelve and beyond. The STEP 1 data show the steepest downward slope in weight occurring in that middle period, with a gradual plateau as weight loss naturally slows over time.
Patients who reach and sustain the 2.4 mg maintenance dose typically report the most noticeable changes between months three and six. By then, the shifts are not just felt, they are visible. For context on how Wegovy's results profile compares with tirzepatide, our Wegovy treatment overview covers the clinical comparison alongside what the 7.2 mg dose approval means for people who respond well to semaglutide.
People sometimes ask us whether there is a point at which Wegovy has clearly not worked. NICE guidance on semaglutide notes that if weight loss is less than 5% after six months at the maintenance dose, continuing should be reviewed by the prescriber. That review is a clinical conversation, not an automatic stop, individual circumstances matter. Understanding when you start to see weight loss on Wegovy can help you set realistic expectations for those early months, and our detailed look at how long Wegovy takes to work explores that further.
Starting weight plays a role, people with higher absolute body weight may see larger absolute losses earlier, even if the percentage reduction looks similar. Diet quality matters considerably; semaglutide reduces appetite but does not override a diet of very high-calorie foods. Sleep, stress and physical activity all feed into the biological context in which the medicine works.
Tolerability is another factor. If nausea at a dose increase leads someone to eat less intentionally or to feel unwell, temporary scale changes can occur for the wrong reasons. Conversely, if GI side effects are severe enough to affect normal eating, that is a reason to contact your prescriber, not to push through alone.
The cost of private Wegovy treatment is something many people weigh up when deciding whether to start; our Wegovy price comparison lays out what private pricing typically looks like and what an honest total cost includes. For anyone thinking about weight-loss treatment options more broadly, it is worth understanding how the different licensed medicines compare before making a decision.
A question our prescribers hear regularly is whether switching to a higher dose faster will accelerate results. It will not, safely. The titration schedule exists because jumping doses increases the risk of significant nausea and other GI effects without meaningfully improving long-term outcomes. If you are curious about when you start seeing weight loss on Wegovy, the honest answer is that the timeline for results is built into the design of the treatment itself.
If you have specific questions about your own situation (starting weight, previous treatments, other medicines you take) speaking to our prescribers through a free consultation is the right place to start. There is no obligation, and our clinical team reviews every consultation the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.